| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 20 |
| NetGPI | no | yes: 0, no: 20 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HIQ2
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 21 |
| GO:0003723 | RNA binding | 4 | 21 |
| GO:0005488 | binding | 1 | 21 |
| GO:0097159 | organic cyclic compound binding | 2 | 21 |
| GO:1901363 | heterocyclic compound binding | 2 | 21 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.309 |
| CLV_PCSK_KEX2_1 | 103 | 105 | PF00082 | 0.532 |
| CLV_PCSK_PC1ET2_1 | 103 | 105 | PF00082 | 0.571 |
| CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.543 |
| CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.474 |
| DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.591 |
| DOC_CKS1_1 | 136 | 141 | PF01111 | 0.411 |
| DOC_CYCLIN_RxL_1 | 103 | 115 | PF00134 | 0.459 |
| DOC_MAPK_gen_1 | 103 | 111 | PF00069 | 0.506 |
| DOC_MAPK_gen_1 | 3 | 9 | PF00069 | 0.409 |
| DOC_MAPK_MEF2A_6 | 70 | 77 | PF00069 | 0.423 |
| DOC_MAPK_MEF2A_6 | 80 | 87 | PF00069 | 0.437 |
| DOC_PP1_RVXF_1 | 2 | 9 | PF00149 | 0.504 |
| DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.632 |
| DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.404 |
| DOC_WW_Pin1_4 | 135 | 140 | PF00397 | 0.516 |
| DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.441 |
| LIG_14-3-3_CanoR_1 | 107 | 112 | PF00244 | 0.333 |
| LIG_14-3-3_CanoR_1 | 23 | 31 | PF00244 | 0.517 |
| LIG_APCC_ABBA_1 | 34 | 39 | PF00400 | 0.530 |
| LIG_Clathr_ClatBox_1 | 108 | 112 | PF01394 | 0.333 |
| LIG_FHA_2 | 108 | 114 | PF00498 | 0.343 |
| LIG_FHA_2 | 49 | 55 | PF00498 | 0.555 |
| LIG_LIR_Apic_2 | 135 | 139 | PF02991 | 0.414 |
| LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.480 |
| LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.479 |
| LIG_PTB_Apo_2 | 14 | 21 | PF02174 | 0.491 |
| LIG_PTB_Phospho_1 | 14 | 20 | PF10480 | 0.491 |
| LIG_SH2_CRK | 136 | 140 | PF00017 | 0.406 |
| LIG_SH2_CRK | 28 | 32 | PF00017 | 0.530 |
| LIG_SH2_NCK_1 | 44 | 48 | PF00017 | 0.471 |
| LIG_SH2_SRC | 44 | 47 | PF00017 | 0.508 |
| LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.477 |
| LIG_SH3_3 | 120 | 126 | PF00018 | 0.536 |
| LIG_SUMO_SIM_par_1 | 107 | 113 | PF11976 | 0.467 |
| LIG_SUMO_SIM_par_1 | 73 | 79 | PF11976 | 0.444 |
| LIG_TRAF2_1 | 99 | 102 | PF00917 | 0.543 |
| LIG_TYR_ITIM | 47 | 52 | PF00017 | 0.477 |
| LIG_UBA3_1 | 74 | 80 | PF00899 | 0.469 |
| MOD_CK1_1 | 10 | 16 | PF00069 | 0.546 |
| MOD_CK1_1 | 79 | 85 | PF00069 | 0.457 |
| MOD_CK2_1 | 107 | 113 | PF00069 | 0.340 |
| MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.291 |
| MOD_GSK3_1 | 23 | 30 | PF00069 | 0.459 |
| MOD_GSK3_1 | 7 | 14 | PF00069 | 0.546 |
| MOD_GSK3_1 | 79 | 86 | PF00069 | 0.396 |
| MOD_N-GLC_1 | 10 | 15 | PF02516 | 0.330 |
| MOD_NEK2_1 | 7 | 12 | PF00069 | 0.499 |
| MOD_NEK2_2 | 27 | 32 | PF00069 | 0.467 |
| MOD_NEK2_2 | 83 | 88 | PF00069 | 0.504 |
| MOD_OFUCOSY | 64 | 69 | PF10250 | 0.527 |
| MOD_Plk_1 | 10 | 16 | PF00069 | 0.530 |
| MOD_Plk_1 | 45 | 51 | PF00069 | 0.508 |
| MOD_Plk_4 | 83 | 89 | PF00069 | 0.479 |
| MOD_ProDKin_1 | 135 | 141 | PF00069 | 0.519 |
| MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.440 |
| TRG_DiLeu_BaLyEn_6 | 104 | 109 | PF01217 | 0.317 |
| TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.477 |
| TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.471 |
| TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.459 |
| TRG_Pf-PMV_PEXEL_1 | 107 | 112 | PF00026 | 0.593 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5Z2 | Leptomonas seymouri | 85% | 100% |
| A0A0N1I2T7 | Leptomonas seymouri | 29% | 100% |
| A0A0S4J311 | Bodo saltans | 30% | 100% |
| A0A0S4JKJ5 | Bodo saltans | 47% | 76% |
| A0A0S4JP51 | Bodo saltans | 32% | 71% |
| A0A1X0P0Y7 | Trypanosomatidae | 26% | 100% |
| A0A1X0P102 | Trypanosomatidae | 29% | 100% |
| A0A1X0P2H6 | Trypanosomatidae | 52% | 100% |
| A0A3Q8II67 | Leishmania donovani | 92% | 100% |
| A0A3Q8IMA7 | Leishmania donovani | 30% | 100% |
| A4HLK8 | Leishmania braziliensis | 30% | 100% |
| A4I5Z5 | Leishmania infantum | 92% | 100% |
| A4I919 | Leishmania infantum | 30% | 100% |
| C9ZRC4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 92% |
| E9B192 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
| E9B3Y4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
| Q4Q440 | Leishmania major | 28% | 100% |
| Q4Q6X2 | Leishmania major | 91% | 100% |
| V5BSJ4 | Trypanosoma cruzi | 53% | 93% |